What Amigo AI does
Amigo AI builds clinical AI agents that interact directly with patients across healthcare workflows including intake, triage, scheduling, pre-visit prep, follow-up and clinical documentation. The company trains its agents through a simulation system it calls the "Amigo Digital Residency," using millions of simulated clinical scenarios before deployment. Amigo says its agents completed over three million patient encounters in the six months before its Series A with zero safety incidents. The company's clinical AI powers organizations including Eucalyptus, Diverge Health and The Care Clinic, according to the company.
Amigo AI is a healthcare tool on Falcoscan. Clinical AI agents that handle patient intake, triage and follow-up. Falcoscan rates Amigo AI with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Amigo AI is founded in 2023, currently at Series_a stage. Pricing: Paid.